293 Development of a MUC16-specific CAR-T cell exhibiting potent antitumor activity for the treatment of patients with recurrent ovarian cancer

293 Development of a MUC16-specific CAR-T cell exhibiting potent antitumor activity for the treatment of patients with recurrent ovarian cancer

Bibliographic Details
Main Authors:	Prashant R Nambiar, Nicole A Protheroe, Kelly DellaGrotte, Harini Kantamneni, Sumati Sundaram, Scott F Heller, Christina Ferren, Collin Walter, Corinne Decker, Alison Crawford, Tina Chang Albershardt
Format:	Article
Language:	English
Published:	BMJ Publishing Group 2023-11-01
Series:	Journal for ImmunoTherapy of Cancer

Similar Items

In Vivo Bioluminescence Visualization of Antitumor Effects by Human MUC1 Vaccination
by: Yong Hyun Jeon, et al.
Published: (2007-09-01)

Furan-Conjugated Tripeptides as Potent Antitumor Drugs
by: Hunain Ali, et al.
Published: (2020-12-01)

Potent antitumor property of Allium bakhtiaricum extracts
by: Kosar Vafaee, et al.
Published: (2019-06-01)

Single domain based bispecific antibody, Muc1-Bi-1, and its humanized form, Muc1-Bi-2, induce potent cancer cell killing in muc1 positive tumor cells.
by: Yumei Li, et al.
Published: (2018-01-01)

Discovery of Novel Quinazoline Derivatives as Potent Antitumor Agents
by: Zhenxi Niu, et al.
Published: (2022-06-01)

Preclinical Studies of Granulysin-Based Anti-MUC1-Tn Immunotoxins as a New Antitumoral Treatment
by: Patricia Guerrero-Ochoa, et al.
Published: (2022-05-01)

MUC1, MUC2, MUC4, MUC5AC, Cdx2: immunohistochemical characteristics in polyps and adenocarcinoma of distal colon
by: M. A. Shyshkin
Published: (2019-05-01)

Synthetic self‐adjuvanted multivalent Mucin 1 (MUC1) glycopeptide vaccines with improved in vivo antitumor efficacy
by: Yang Zhou, et al.
Published: (2024-02-01)

Antitumor effect of a novel humanized MUC1 antibody-drug conjugate on triple-negative breast cancer
by: Lan Li, et al.
Published: (2023-04-01)

Associations between the expression of mucins (MUC1, MUC2, MUC5AC and MUC6) and clinicopathologic parameters of human breast carcinomas
by: Onur Oral, et al.
Published: (2020-01-01)

Degradation of MUC7 and MUC5B in human saliva.
by: Sachiko Takehara, et al.
Published: (2013-01-01)

MUC16 mutations improve patients’ prognosis by enhancing the infiltration and antitumor immunity of cytotoxic T lymphocytes in the endometrial cancer microenvironment
by: Jing Hu, et al.
Published: (2018-10-01)

Expressão de CDX2 e mucinas (MUC1, MUC2, MUC5AC e MUC6) em esôfago de Barrett antes e após fundoplicatura de Nissen Expression of CDX2 and mucins (MUC1, MUC2, MUC5AC and MUC6) in Barrett's esophagus before and after Nissen fundoplication
by: Luciana Rodrigues de Meirelles, et al.
Published: (2012-10-01)

Evaluation of MUC1, MUC2, MUC5AC, and MUC6 Expression Differences in Lung Adenocarcinoma Subtypes by Using a Final Immunoreactivity Score (FIRS)
by: Melek BUYUK, et al.
Published: (2023-01-01)

Monomethyl auristatin E Exhibits Potent Cytotoxic Activity against Human Cancer Cell Lines SKBR3 and HEK293
by: Meghdad Abdollahpour-Alitappeh, et al.
Published: (2017-10-01)

Clinicopathological Study of Carcinoma of the Ampulla of Vater with Special Reference to MUC1, MUC2 and MUC5AC Expression
by: Maithili Mandar Kulkarni, et al.
Published: (2017-05-01)

MUC1 and MUC16: critical for immune modulation in cancer therapeutics
by: Xinyi Chen, et al.
Published: (2024-02-01)

The Adjuvant of α-Galactosylceramide Presented by Gold Nanoparticles Enhances Antitumor Immune Responses of MUC1 Antigen-Based Tumor Vaccines
by: Liu Y, et al.
Published: (2021-01-01)

A1-reprogrammed mesenchymal stromal cells prime potent antitumoral responses
by: Marina Pereira Gonçalves, et al.
Published: (2024-03-01)

Potent Antitumor Activity Generated by a Novel Tumor Specific Cytotoxic T Cell.
by: Zheng Wang, et al.
Published: (2013-01-01)

Tumor-targeted silencing of the peptide transporter TAP induces potent antitumor immunity
by: Greta Garrido, et al.
Published: (2019-08-01)

Potent antitumor effects of cell-penetrating peptides targeting STAT3 axis
by: Maryam Aftabizadeh, et al.
Published: (2021-01-01)

Discovery of a Novel Hybrid of Vorinostat and Riluzole as a Potent Antitumor Agent
by: Qifu Xu, et al.
Published: (2020-07-01)

Immunohistochemical detection of MUC5AC and MUC5B mucins in ferrets
by: David K. Meyerholz, et al.
Published: (2023-06-01)

Comparison of the transmembrane mucins MUC1 and MUC16 in epithelial barrier function.
by: Ilene K Gipson, et al.
Published: (2014-01-01)

Immunohistochemical study of MUC5AC, MUC1, MUC2, Cdx-2 in hyperplastic polyps and intestinal-type gastric adenocarcinoma
by: V. A. Tumanskiy, et al.
Published: (2017-10-01)

Immunohistochemical expression profiles of MUC1 and MUC2 mucins in urothelial tumors of bladder
by: Ipek Isik Gonul, et al.
Published: (2018-01-01)

Purification and interactions of the MucA’ and MucB proteins constituting the DNA polymerase RI
by: Petr Grúz, et al.
Published: (2019-05-01)

Multiple stimuli-responsive nanosystem for potent, ROS-amplifying, chemo-sonodynamic antitumor therapy
by: JunJie Tang, et al.
Published: (2022-09-01)

Mesothelin-based CAR-T cells exhibit potent antitumor activity against ovarian cancer
by: Jing Guo, et al.
Published: (2024-04-01)

Autonomous IL-36R signaling in neutrophils activates potent antitumor effector functions
by: Sumedha Roy, et al.
Published: (2023-06-01)

A novel VEGFR inhibitor ZLF-095 with potent antitumor activity and low toxicity
by: Xiao Li, et al.
Published: (2023-05-01)

Morusin shows potent antitumor activity for melanoma through apoptosis induction and proliferation inhibition
by: Wei Liu, et al.
Published: (2023-06-01)

Potent antitumor activity of a glutamyltransferase-derived peptide via an activation of oncosis pathway
by: Cheng Fang, et al.
Published: (2021-08-01)

Expression profile of mucins (MUC2, MUC5AC and MUC6) in <it>Helicobacter pylori </it>infected pre-neoplastic and neoplastic human gastric epithelium
by: Reis Celso A, et al.
Published: (2006-03-01)

Oncolytic adenovirus with MUC16-BiTE shows enhanced antitumor immune response by reversing the tumor microenvironment in PDX model of ovarian cancer
by: Qiuman Wang, et al.
Published: (2022-12-01)

Zinc protoporphyrin IX, a heme oxygenase-1 inhibitor, demonstrates potent antitumor effects but is unable to potentiate antitumor effects of chemotherapeutics in mice
by: Jozkowicz Alicja, et al.
Published: (2008-07-01)

Contribuíram nesta edição (29.3)
Published: (2021-06-01)

Contribuíram nesta edição (29.3)
Published: (2021-06-01)

Pré-textuais / Sumário 29.3
by: Yara Elizabeth Alves
Published: (2021-01-01)